Mission and Objectives:：
Cancer serves as a prominent example of epigenetic variations. The pioneering research in cancer biology worldwide has indicated that comprehensive genomic sequencing can unravel the molecular mechanisms underlying cancer, offering insights into cancer prevention, diagnosis, prognosis, and potential novel treatment strategies. In light of this, the Cancer Genomics Research Center employs whole-genome sequencing platforms to further explore and identify new functional and molecular features of epigenetic regulation. By actively collaborating with clinical physicians, we aim to develop advanced methods for cancer diagnosis and treatment, ultimately striving to improve human healthcare and well-being.
Future Prospects:
We are dedicated to utilizing various whole-genome sequencing technologies, including RNA-seq, ATAC-seq, ChIP-seq, 6mA-seq, and more, to address critical and unresolved biological and medical questions in the fields of tumor biology and drug addiction. In the future, we aim to develop single-cell whole-genome sequencing technologies and assist our institution in providing comprehensive support for whole-genome sequencing. This will enable us to identify potential driver factors contributing to tumor progression from different cancer types, validate molecular mechanisms, assess prognostic significance for patients, and explore potential novel treatment approaches.